Relafen: A New Drug with an Old Danger
Individuals who regularly take Relafen (nabumetone) or other anti-inflammatory medications, either for arthritis, joint pain, or other indications, should be aware of severe adverse health implications that can potentially result from prolonged use.
Relafen is usually prescribed for osteoarthritis or rheumatoid arthritis to reduce pain, inflammation, and stiffness, but can also be prescribed for other purposes.
Relafen works by reducing the level of hormones in the body that can cause pain and inflammation.
In addition to the warnings provided with the packaging of the medication and those related by a physician, there are other important concerns that users of Relafen should know about.
A severe adverse reaction called Stevens-Johnson Syndrome has been linked to use of the drug Relafen.
Relafen is in a class of drugs known as nonsteroidal anti-inflammatory medications (NSAIDs) that have been linked to allergic skin reactions, including severe cases such as Stevens-Johnson Syndrome.
Other possible allergic reactions include urticaria, dyspnea, anaphylaxis, and the severe symptoms associated with Stevens-Johnson Syndrome.
Stevens-Johnson Syndrome is a severe allergic reaction to certain drugs. In addition to NSAIDs, antibiotics such as sulfonamides, tetracycline, amoxicillin, and ampicillin have been implicated.
The symptoms of Stevens-Johnson Syndrome typically begin as some form of upper respiratory infection, including also fever, sore throat, inflammation of the mouth, chills, headaches, aching of the joints, and generally feeling ill.
After onset, Stevens-Johnson Syndrome will continue to develop, affecting the various mucous membranes of the body, including the mouth, esophagus, nostrils, eyes, genitals, and anal regions. Lesions may develop and the skin may blister or even detach in severe cases.
If any of these symptoms lead to the belief that the onset of Stevens-Johnson Syndrome is occurring, immediate treatment is imperative.
Sufferers of Stevens-Johnson Syndrome should be transported to an emergency room immediately, and will likely be treated in a intensive care burn unit.
Even after treatment, long-term effects of Stevens-Johnson Syndrome can include scarring, eye and vision problems, and even death.
Some studies predict a 3-15% mortality rate in individuals with Stevens-Johnson Syndrome if left untreated. Any individuals with a known family history of adverse drug reactions, even if minor, should carefully consult with their physicians before taking Relafen or other anti-inflammatory drugs.
Above all, it is crucial to be fully aware of all risks associated with the use of any drug.
Call toll free 1.888.227.2771
Send Us Email
[Home]
[About the Firm]
[Our Staff]
[Experience]
[Service]
[Results]
[Our Philosophy]
[Product Liability]
[California Car Accident Law]
[Elder Abuse]
[Dog Bite Statistics]
[What To Do After An Animal Bite]
[Legal Recovery for Dog Bites]
[Animal Bite Links]
[Truck Accident Information]
[Insurance Bad Faith]
[Duties of Insurance Companies]
[Department of Insurance Help Line]
[First Party]
[Time Limits]
[Relafen]
[Stevens-Johnson Syndrome]
[Legal Links]
[Disclaimer]
The Law Office of Robert Bruce Arnold
Injury and Insurance Lawyers
Established 1980
2329 India Street
San Diego, CA.
Tel (619) 233-1096
Fax (619) 233-1607
Toll Free 1-888-227-2771
We cannot represent or accept clients from states where marketing materials in this website do not comply
with local ethic rules of said state. This site is not intended to and does not create an attorney client relationship and does
not constitute legal advice. Links in this site are not guaranteed to be accurate or up to date and are not endorsed or guaranteed
by this firm.
